Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Blog Blog | 23 September 2020 Research and development Italy Transparency matters: Italy moves against the secrecy surrounding the cost of medicines Statement | 22 September 2020 COVID-19 MSF statement at EU Parliament hearing on COVID-19 vaccines Technical brief | 14 September 2020 Intellectual property and trade MSF Position on the European Commission’s Roadmap for Pharmaceutical Strategy Issue brief Issue brief | 01 September 2020 Tuberculosis Advancing Access through Market Interventions: Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down Technical brief | 24 August 2020 COVID-19 Access Challenges to COVID-19 Therapeutic Candidates Technical brief | 17 August 2020 Intellectual property and trade Médecins Sans Frontières feedback on the European Commission’s roadmap for an Intellectual Property Action Plan Blog Blog | 13 August 2020 COVID-19 Monoclonal antibodies may be a COVID-19 game changer. But will they be accessible to everyone ? Blog Blog | 05 August 2020 COVID-19 We need strings attached! Load More
Blog Blog | 23 September 2020 Research and development Italy Transparency matters: Italy moves against the secrecy surrounding the cost of medicines
Technical brief | 14 September 2020 Intellectual property and trade MSF Position on the European Commission’s Roadmap for Pharmaceutical Strategy
Issue brief Issue brief | 01 September 2020 Tuberculosis Advancing Access through Market Interventions: Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down
Technical brief | 17 August 2020 Intellectual property and trade Médecins Sans Frontières feedback on the European Commission’s roadmap for an Intellectual Property Action Plan
Blog Blog | 13 August 2020 COVID-19 Monoclonal antibodies may be a COVID-19 game changer. But will they be accessible to everyone ?
